Malek Shatila

Statistics

Publications

Citations

155

H-Index

Active since

2022

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Baylor College of Medicine

Imperial College London

Cleveland Clinic

Malek Shatila is an author at The University of Texas MD Anderson Cancer Center specializing in immunology, inflammation, and immune-mediated colitis.

ORCID

Publications per year

2022–2024

Publications

Immune-related adverse events after immune checkpoint inhibitor exposure in adult cancer patients with pre-existing autoimmune diseases

Antonio Pizuorno Machado, Malek Shatila, Cynthia Liu et al. · Journal of Cancer Research and Clinical Oncology · 2023 · 59 citations · Full text

Life Sciences, Immunology, Oncology +17

IL12/23 Blockade for Refractory Immune-Mediated Colitis: 2-Center Experience

Anusha Shirwaikar Thomas, Seung Eun Lee, Malek Shatila et al. · The American Journal of Gastroenterology · 2023 · 26 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Clinical characteristics and outcomes of tyrosine kinase inhibitor-related lower GI adverse effects

Cynthia Liu, Rajan Amin, Malek Shatila et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 16 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients

Yinghong Wang, Hamzah Abu‐Sbeih, Tenglong Tang et al. · Gastrointestinal Endoscopy · 2024 · 16 citations · Full text

Medicine, Immunology, Pathology +14

First-line treatment of fecal microbiota transplantation for immune-mediated colitis.

Yinghong Wang, Krishnavathana Varatharajalu, Malek Shatila et al. · Journal of Clinical Oncology · 2023 · 15 citations

Veterinary Medicine, Immunology, Internal Medicine +13

1–5 of 7